Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 58.40
+0.40 (0.69%)
At close: Mar 4, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.27 billion as of March 4, 2026. Its market cap has increased by 28.92% in one year.
Market Cap
6.27B
Enterprise Value
10.29B
Revenue
9.52B
Ranking
n/a
PE Ratio
11.71
Stock Price
58.40
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.27B, an increase of 121.21%. That is a compound annual growth rate of 26.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 6.27B | 12.52% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 24.53B |
| The ACME Laboratories | 16.82B |
| The IBN SINA Pharmaceutical Industry | 10.25B |
| Asiatic Laboratories | 7.44B |
| Orion Pharma | 7.23B |
| Techno Drugs | 4.11B |
| Ambee Pharmaceuticals | 1.83B |
| Pharma Aids | 1.74B |